Cardiff Oncology

IPO

Public · San Diego, United States · Founded 1999 · $55.0M raised

Employees
11–50
Founded
1999
Business Model
B2B
Total Funding
$55.0M
Last Round
$40.0M Growth EquityDec 2024
Rounds
2
Type
Public

About

Clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies.

Summary

Cardiff Oncology is a Biotech company based in San Diego, United States, founded in 1999. It has raised $55.0M in total across 2 rounds, most recently a $40.0M Growth Equity round in Dec 2024. Investors include Pfizer Ventures, Frazier Healthcare and CAM Capital.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Growth EquityGrowth EquityDec 2024
$40.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies